|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Non alcoholic fatty liver disease and metabolic syndrome显示文摘 | Paschos P Paletas K | 2009 | Hippokratia2009，13，1： | 1 |
| 2 | Non alcoholic fatty liver disease and meta- bolic syndrome显示文摘 | Paschos P Paletas K | 2009 | Hippokratia2009，13，1： | 1 |
| 3 | Methyl 3,3,3 -trifluoropyruvate hemiaminals:Stability and transaminations显示文摘 | Jaroshv Kvl' c ala Oldr ich Paleta | 2005 | Journal of Fluorine Chemistry2005，126，： | 1 |
| 4 | Dipeptidyl pepti- dase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis 显示文摘 | Karagiannis T Paschos P Paletas K | 2012 | BMJ2012，344，： | 1 |
| 5 | Common variants in FTO,MC4R,TMEM18,PRL,AIF1,and PCSK1 show evidence of association with adult obesity in the Greek population显示文摘 | Rouskas K Kouvatsi A Paletas K Papazoglou D Tsapas A Lobbens S Vatin V Durand E Labrune Y Delplanque J Meyre D and Froguel P | | 0，，02： | 1 |
| 6 | Dipeptidyl pepli- dase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting:systematic review and meta-analysis 显示文摘 | Karagiannis T Paschos P Paletas K | 2012 | BMJ2012，344，3： | 1 |
| 7 | Non alcoholic fatty liver disease and metalbolic syndrome显示文摘 | Faschos P Paletas K | | 0，，： | 1 |
| 8 | Dipeptidylpeptidase-4 inhibitors for treatment of type 2 diabetes mellitus inthe clinical setting: systematic review and meta - analysis 显示文摘 | KARAGIANNIS T PASCHOS P PALETAS K et d | 2012 | BMJ2012，344，： | 1 |
| 9 | Preparation of friflauorohalomethylmagnesium halides using highly active magnesium metal and their reactions显示文摘 | Jaroslav Kvlcala Jan Stambasky Martin Skalicky Oldrich Paleta | 2005 | Journal of Fluorine Chemistry2005，126，： | 1 |
| 10 | Unusual β, β-coupling and 13- alkylation of methyl 2, 3, 3-trifluoropropenoate by lithium diorganocuprates显示文摘 | Hajduch J Paleta O | 2011 | Journal of Fluorine Chemistry2011，132，2： | 1 |
| 11 | Preparation of new trifluoromethyl substituted tri-and tetracyclic heterocycles with peganin skdeton from a methyl 3,3,3 -trifluoropyruvate /2 -aminobenzylamine adduct显示文摘 | Jaroslav Kvabala Oldfich Paleta | 1996 | Tetrahedron Letters1996，37，38： | 1 |
| 12 | Non alcoholic fatty liver disease and metabolic syndrome显示文摘 | Paschos P Paletas K | 2009 | Hippokratia2009，13，1： | 1 |
| 13 | New fluorinated nucleoside analogues with 2-butenolide rings prepared by nucle- ophilic vinylic fluorine displacement in 4, 4-dialkyl-2, 3-difluorobut-2-en-4-olides显示文摘 | Paleta O Duda Z Holy A | 2001 | Mendeleev Communica- tions2001，11，1： | 1 |
| 14 | Dipepti- dyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis显示文摘 | KARAGIANNIS T PASCHOS P PALETAS K | 2012 | BMJ2012，344，： | 1 |
| 15 | Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and me- ta-analysis显示文摘 | Karagiannis T Paschos P Paletas K | 2012 | BMJ2012，344，12： | 1 |
| 16 | Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis显示文摘 | Karagiannis T Paschos P Paletas K | 2012 | BMJ2012，344，： | 1 |
| 17 | Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis 显示文摘 | Karagiannis T Paschos P Paletas K | 2012 | BMJ2012，344，： | 1 |
| 18 | Non alcoholic fatty liver disease and metabolic syndrome 显示文摘 | Paschos P Paletas K | 2009 | Hippokratia2009，13，1： | 1 |
| 19 | Dipeptidyl pep- tidase-4 inhibitor for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and analysis 显示文摘 | Karagiannis T Paschos D Paletas K | 2012 | BMJ2012，344，1： | 1 |
| 20 | Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis显示文摘 | Karagiannis T Pasehos P Paletas K | 2012 | Bri Med J2012，344，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员